26 May 2013
Keywords: s-p, claritin, woes, hit, third, quarter, sales
Article | 27 October 2003
Ailing US drug major Schering-Plough has reported a sharp decrease inrevenues for the third quarter of 2003 as the firm continued ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.